Figure 5From: Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasisDovitinib inhibited tumor angiogenesis in vivo. A) Treatment with dovitinib decreased microvessel density in a dose-dependent manner. Black star, P < 0.01 relative to the control group. B) Immunohistochemical staining of CD34 showing microvessels in xenograft tumors. Scale bars, 100 μm.Back to article page